Figure 1  .

Flow chart of the 974 dyspeptic patients who entered the run in week with low dose antacid treatment. A=not randomized after run in period for reasons other than response to antacid treatment (n=52). B=H pylori positive responders not entering follow up (n=17). C=H pylori negative responders not entering follow up (n=19). Responder=no dyspeptic symptoms requiring further management after the two week double blind treatment (main outcome criterion). Hp, Helicobacter pylori; recur.,recurrence of dyspeptic symptoms requiring management